July is Dry Eye Month at Prevent Blindness with Goal to Raise Awareness and Educate the Public on the Eye Condition
Prevent Blindness provides a variety of free dry eye educational resources including a dedicated webpage, fact sheets and graphics in English and Spanish, expert interviews and informative videos.
CHICAGO, June 25, 2025 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading patient advocacy organization dedicated to preventing blindness and preserving sight, is once again declaring July as Dry Eye Month with the goal to raise awareness and educate the public and healthcare professionals on dry eye. The National Eye Institute states that nearly 16.4 million Americans have dry eye. And, if severe dry eye is not treated, it can sometimes damage the cornea and negatively impact quality of life.
Prevent Blindness has created a variety of free dry eye resources including a dedicated webpage, fact sheets and social media graphics available in English and Spanish, and videos, including how to apply eye drops. For the fifth consecutive year, OCuSOFT ® Inc., a privately held eye and skin care company dedicated to innovation in eyelid hygiene and ocular health, is partnering with Prevent Blindness in support of Dry Eye Month.
Two featured interviews in the Prevent Blindness Focus on Eye Health Expert Series include:
"Dry Eye Disease and Meibomian Gland Dysfunction (MGD): What You Need to Know" with April Jasper, OD, FAAO, of Advanced Eyecare Specialists.
Risk factors for dry eye include:
Being more than 50 years old
Hormonal changes or medicines that affect hormones
Refractive surgery (for example, Lasik)
Inflammation of the eyelids
Environmental conditions, such as allergies, exposure to smoke, or a dry climate
Contact lenses
Poor make-up hygiene
Medical conditions such as rheumatoid arthritis, rosacea, Sjögren syndrome, and certain other autoimmune diseases
Decreased blink rate: Can be caused by frequent computer or device use or occurs in certain diseases, such as Parkinson's
Eyelid conditions that cause eyelids to not close completely
Extended screen time on digital devices such as a computer, tablet or smart phone
Additionally, certain medicines may cause decreased tear production, including antihistamines, decongestants, hormone replacement therapy, antidepressants, and medicines for high blood pressure, acne, birth control, and Parkinson's disease, according to the Mayo Clinic.
Women are twice as likely to develop dry eye than men. Women who are pregnant or experiencing menopause are also more likely to have dry eye.
"A number of treatment options are available for dry eye that can help address symptoms and save sight," said Jeff Todd, president and CEO of Prevent Blindness. "We invite everyone to check out our free dry eye resources and make an appointment with an eye doctor to find out what type of treatment is best for them."
For more information on dry eye, please visit the Prevent Blindness resource page at PreventBlindness.org/dry-eye. Prevent Blindness also offers a free listing of vision care financial assistance services in English and Spanish at: PreventBlindness.org/vision-care-financial-assistance-information.
About Prevent Blindness Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, X, Instagram, Threads, LinkedIn, TikTok, and YouTube.
Media Contact
Sarah Hecker, Prevent Blindness, 312.363.6035, shecker@preventblindness.org, PreventBlindness.org
View original content to download multimedia:https://www.prweb.com/releases/july-is-dry-eye-month-at-prevent-blindness-with-goal-to-raise-awareness-and-educate-the-public-on-the-eye-condition-302490993.html
SOURCE Prevent Blindness
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
12 minutes ago
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON -- WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___
13 minutes ago
Nestle says it will remove artificial dyes from US foods by 2026
Nestle said Wednesday it will eliminate artificial colors from its U.S. food and beverages by the middle of 2026. It's the latest big food company making that pledge. Last week, Kraft Heinz and General Mills said they would remove artificial dyes from their U.S. products by 2027. General Mills also said it plans to remove artificial dyes from its U.S. cereals and from all foods served in K-12 schools by the middle of 2026. The move has broad support. About two-thirds of Americans favor restricting or reformulating processed foods to remove ingredients like added sugar or dyes, according to an AP-NORC poll. Both California and West Virginia have recently banned artificial dyes in foods served in schools. On Sunday, Republican Gov. Greg Abbott of Texas signed a bill requiring foods made with artificial dyes or additives to contain a new safety label starting in 2027. The label would say they contain ingredients 'not recommended for human consumption' in Australia, Canada, the European Union or the U.K. The federal government is also stepping up its scrutiny of artificial colors. In January, days before President Donald Trump took office, the U.S. regulators banned the dye called Red 3 from the nation's food supply, nearly 35 years after it was barred from cosmetics because of potential cancer risk. In April, Trump's Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said the agency would take steps to eliminate synthetic dyes by the end of 2026, largely by relying on voluntary efforts from the food industry. Nestle has pledged to remove artificial dyes before. Early in 2015, the company said it would remove artificial flavors and colors from its products by the end of that year. But the promise didn't hold. Nestle said Wednesday it's been removing synthetic dyes from its products over the last decade, and 90% of its U.S. portfolio doesn't contain them. Among those that do is Nesquik Banana Strawberry milk, which is made with Red 3. Nestle said Wednesday it wants to evolve with its U.S. customers' changing nutritional needs and preferences. 'Serving and delighting people is at the heart of everything we do and every decision that we make,' Nestle's U.S. CEO Marty Thompson said in a statement.
Yahoo
22 minutes ago
- Yahoo
FDA requires updated warning about rare heart risk with COVID shots
WASHINGTON (AP) — The Food and Drug Administration said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men. Myocarditis, a type of heart inflammation that is usually mild, emerged as a complication after the first shots became widely available in 2021. Prescribing information from both Pfizer and Moderna already advises doctors about the issue. In April, the FDA sent letters to both drugmakers asking them to update and expand the warnings to add more detail about the problem and to cover a larger group of patients. While the FDA can mandate label changes, the process is often more of a negotiation with companies. Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots between the ages of 6 months and 64 years old. The label also notes that the problem has been most common among males ages 12 to 24. The previous label said the problem mostly occurs in 12- to 17-year-olds. The FDA's labeling change appears to conflict with some prior findings of scientists elsewhere in the U.S. government. The Centers for Disease Control and Prevention previously concluded there was no increased risk of myocarditis detected in government vaccine injury databases for COVID-19 shots dating back to 2022. Officials also noted that cases tend to resolve quickly and are less severe than those associated with COVID-19 infection itself, which can also cause myocarditis. The FDA announcement came as new vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. met to debate the continuing use of COVID-19 vaccines for key groups, including pregnant women. It's the first meeting of the CDC advisory panel since Kennedy abruptly dismissed all 17 members of the group, naming a new panel that includes several members with a history of anti-vaccine statements. The FDA's label update is the latest step by officials working under Kennedy to restrict or undercut use of vaccines. FDA Commissioner Marty Makary and a top deputy recently restricted annual COVID-19 shots to seniors and other Americans at higher risk from the virus. They've also suggested seasonal tweaks to match the latest circulating virus strains are new products that require extra testing. Outside experts said the new warning is the wrong approach. 'They are right to suggest that we need to consider myocarditis risks associated with the vaccine, but what they propose is exactly the wrong solution,' said Dr. Robert Morris, a public health specialist at the University of Washington. 'We should be investigating who is prone to myocarditis to see if we can predict and mitigate that risk.' Makary and several other FDA officials gained prominence during the pandemic by suggesting the federal government exaggerated the benefits of COVID-19 boosters and downplayed serious side effects, including myocarditis. Before joining the government, Makary and two of his current FDA deputies wrote a 2022 paper that said mandating booster shots in young people would cause more vaccine-related injuries than prevented hospitalizations from COVID-19 infections. The conclusion contradicted that of many leading vaccine and public health experts at the time, including at the CDC. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
